How to buy Salesforce (CRM) stock from India

Yes, an Indian resident can buy Salesforce — legally, in US dollars, under the RBI's Liberalised Remittance Scheme (LRS). The buying is the easy 10%. The 90% that decides your outcome is tax, estate-tax exposure, and whether Agentforce actually re-accelerates the business. This is the short version.

The 30-second version

• Legal and simple. Buy CRM via any India-facing platform (Vested, INDmoney) or a global broker (Interactive Brokers, Rovia). Whole shares or a fractional rupee amount.
• Small dividend, real buyback. Salesforce paid its first-ever dividend in 2024 (yield ~0.6%, modest); the bigger capital return is the multi-billion-dollar buyback program. 25% US dividend withholding applies but the absolute amount is small.
• India tax on gains: hold more than 24 months → 12.5% LTCG (no indexation); sell sooner → your slab rate. This is Section 112, not the friendlier 112A that Indian shares get.
• The trap most miss: directly-held CRM is a US-situs asset — above $60,000, your estate faces up to 40% US estate tax, with no India-US treaty relief.
• If your thesis is "US enterprise software," VOO/VTI already hold CRM as a meaningful weight — same exposure, no single-stock risk.

Quick facts

Can an Indian resident buy it?	Yes — fully legal under the LRS
Ticker / exchange	CRM / NYSE
How	India-facing platform (Vested, INDmoney) or global broker (IBKR, Rovia)
Minimum	A fraction of one share (fractional lets you invest an exact INR amount)
Dividend	~0.6% yield, paid quarterly since 2024
US dividend withholding	25% for Indian residents (claimable as FTC via Form 67)
India tax on gains	12.5% LTCG after 24 months; else your slab (Section 112)
Estate-tax risk	US-situs above $60k → up to 40%, no treaty relief
Annual compliance	Schedule FA disclosure, every year you hold

How to buy it — 3 steps

1. Open an account and finish KYC. Pick an India-facing platform (Vested, INDmoney) for a simple, India-funded experience, or a global broker (Interactive Brokers, Rovia) for wider access. New to this? Start with how to invest in US stocks from India.
2. Fund it via the LRS. Remit from your Indian bank under the LRS (cap: $250,000 per financial year). 20% TCS applies above INR 10 lakh in a year — but it's a creditable prepayment, not a cost. See LRS explained and the LRS and TCS calculator.
3. Place the order. CRM has historically traded in a wide band (roughly $200–$370 over recent years), so a whole share is affordable — or buy a fractional INR amount.

The tax that actually matters

Salesforce now has both a small dividend and a capital-gains component, so the tax answer has two pieces.

Dividends. Quarterly dividends from CRM are subject to 25% US withholding at source under the India-US tax treaty. The net amount lands in your brokerage cash. In India, dividends are taxable at your slab rate, but you can claim Foreign Tax Credit for the 25% already withheld by filing Form 67 before your ITR. With a ~0.6% yield, the rupee amounts are usually small — but the paperwork is real. See dividend withholding and Form 67 and the Form 67 FTC calculator.

Capital gains. Taxed under Section 112 (foreign shares don't get the Section 112A treatment Indian-listed equity enjoys):

Holding period	Treatment	Rate
24 months or less	Short-term	Your slab rate (up to ~30%+)
More than 24 months	Long-term	12.5%, no indexation

Worked example. Buy 10 shares at $250 when USD/INR is 86 → cost INR 2,15,000. Sell 26 months later at $320 when USD/INR is 88 → proceeds INR 2,81,600. Taxable gain INR 66,600; LTCG at 12.5% = INR 8,325. Note the gain is computed in rupees, so the currency move is baked in. Model your own with the US capital-gains calculator; full rules in how US stocks are taxed in India.

The $60,000 estate-tax trap

Directly-held CRM is a US-situs asset. If the holder dies with more than $60,000 of US-situs assets, the estate faces US estate tax up to 40% — and the India-US treaty does not cover estate tax, so there's no credit or relief. It's the most under-appreciated risk in direct US holding, and the fix (holding through pooled or fund structures instead of direct shares) has to be a deliberate choice made before the position gets large. Full detail: the $60,000 estate-tax trap.

Buy the stock, or get Salesforce through an ETF?

If you want…	Best route
A concentrated bet that CRM re-rates on Agentforce traction	CRM directly
"US enterprise software will keep winning" exposure	VOO or VTI — CRM is a meaningful holding, plus hundreds of others
The least single-stock risk	A broad ETF

Salesforce is a top-25 weight in VOO and VTI, and a substantial position in old-school software ETFs that lean toward established SaaS rather than pure-play AI names. An index fund already gives you CRM exposure proportional to its size. Compare the two routes in direct stocks vs US ETFs and best US ETFs for Indian investors; the broader ETF case is in US ETFs for Indians.

The business in one screen

What it is: Salesforce sells the dominant cloud CRM platform (Customer 360), bolted to a suite of acquisitions — Slack (messaging), Tableau (BI), MuleSoft (integration), and Data Cloud — and is now monetizing AI through Agentforce, its autonomous-agent layer.

Bull case	Bear case
Dominant CRM franchise with high net-revenue retention	Revenue growth has slowed to low double-digits, may keep decelerating
Agentforce as the per-conversation, per-action AI monetization vector	Agentforce pricing model has changed three times; unproven at scale
Free-cash-flow margin expansion as buybacks shrink the share count	Integration overhang from Slack, Tableau, MuleSoft mega-deals
Sticky enterprise base, multi-product cross-sell	Microsoft Copilot for Sales and HubSpot pressing from above and below

Exact valuation is in the live widget above — a good business, no longer priced like a hypergrowth one.

Our take

Verdict: HOLD — quality franchise, slower growth, AI optionality unproven. Worth a small position, not a core overweight.

• The bull side is real. Salesforce is genuinely the system of record for sales and service at most large enterprises, and Agentforce ARR is growing fast off a small base — if per-action pricing scales, the operating leverage is significant.
• The risks are equally real. Growth has decelerated for several years running, the AI monetization model is still being rewritten, and Microsoft Copilot for Sales plus HubSpot are credible competitive threats. A re-rating in either direction is possible.
• Position sizing matters more than entry timing. Treat CRM as a quality-software satellite, not a compounder you bet the portfolio on.

Compliance note. Vested.blog is not a SEBI-registered Research Analyst. The above is an editorial opinion for educational illustration only — not investment advice and not a regulated stock recommendation. Vested.blog is published by Rovia; the publisher and its affiliates may hold positions in stocks discussed. Make your own decisions or consult a SEBI-registered advisor.

Risks to size for

• Growth deceleration: low double-digit revenue growth is the new base case, not a temporary dip.
• AI monetization uncertainty: Agentforce pricing has already gone through several iterations; the eventual unit economics are still being discovered.
• Currency: your return is in USD but you spend rupees — see the rupee-dollar effect.

Two things people forget

• Schedule FA: disclose CRM in Schedule FA of your ITR every year you hold it — even if bought and sold within the year, even at a loss. Non-disclosure carries Black Money Act penalties. Use the Schedule FA helper.
• Dividend paperwork: because CRM now pays a dividend, claiming the 25% US withholding back as Foreign Tax Credit means filing Form 67 before your ITR. Easy to miss in the first year of ownership.

Bottom line

Buying CRM from India is easy and legal. What needs thought isn't the buying — it's that Salesforce is a Section-112 capital-gains play (12.5% after 24 months) with a small but real dividend angle (25% US withholding, FTC via Form 67), a US-situs asset with a $60k estate-tax trap, and a slower-growth software franchise where AI optionality is the swing factor. If your real thesis is "US enterprise software," an ETF gives you the exposure without the concentration. For the full picture of accounts and options, start at the US investing hub.

---

This article is general information, not personalised investment, tax, or legal advice. Rules, rates, and thresholds described here are as of 2026 and can change; verify the current position and consult a qualified advisor before acting.